UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 244

Sortiert nach

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.JCO2001225-3324

2020

Volltextzugriff (PDF)

Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1830-1835

2008

Volltextzugriff (PDF)

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

The lancet oncology, 2010-12, Vol.11 (12), p.1142-1148

2010

Volltextzugriff (PDF)

Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans

Hepatology (Baltimore, Md.), 2014-07, Vol.60 (1), p.257-266

2014

Volltextzugriff (PDF)

Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma

Annals of surgical oncology, 2008-10, Vol.15 (10), p.2787-2794

2008

Volltextzugriff (PDF)

HMGB1-Mediated Cell Death—A Crucial Element in Post-Hepatectomy Liver Failure

International journal of molecular sciences, 2024-07, Vol.25 (13), p.7150

2024

Volltextzugriff (PDF)

Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection

PloS one, 2016-11, Vol.11 (11), p.e0165481-e0165481

2016

Volltextzugriff (PDF)

Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans

Journal of hepatology, 2017-12, Vol.67 (6), p.1243-1252

2017

Volltextzugriff (PDF)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement

Frontiers in oncology, 2023-08, Vol.13, p.1225154

2023

Volltextzugriff (PDF)

Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4202

2024

Volltextzugriff (PDF)

Perioperative and palliative systemic treatments for biliary tract cancer

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359241230756-17588359241230756

2024

Volltextzugriff (PDF)

Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial

Cancers, 2024-02, Vol.16 (5), p.857

2024

Volltextzugriff (PDF)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

BMC cancer, 2008-04, Vol.8 (1), p.120-120, Article 120

2008

Volltextzugriff (PDF)

Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis

Annals of surgical oncology, 2011-05, Vol.18 (5), p.1380-1388

2011

Volltextzugriff (PDF)

Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program

Gut microbes, 2023-12, Vol.15 (1), p.2176119-2176119

2023

Volltextzugriff (PDF)

Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity

PloS one, 2017-04, Vol.12 (4), p.e0175359-e0175359

2017

Volltextzugriff (PDF)

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918787993-1758835918787993

2018

Volltextzugriff (PDF)

Activated Mammalian Target of Rapamycin Is an Adverse Prognostic Factor in Patients with Biliary Tract Adenocarcinoma

Clinical cancer research, 2007-08, Vol.13 (16), p.4795-4799

2007

Volltextzugriff (PDF)

The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer

Cancers, 2023-05, Vol.15 (11), p.2900

2023

Volltextzugriff (PDF)

Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction

PloS one, 2015-01, Vol.10 (1), p.e0116985-e0116985

2015

Volltextzugriff (PDF)

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis

Cell death discovery, 2023-08, Vol.9 (1), p.282-282, Article 282

2023

Volltextzugriff (PDF)

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Frontiers in oncology, 2023-08, Vol.13, p.1231600-1231600

2023

Volltextzugriff (PDF)

Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer

PloS one, 2012-09, Vol.7 (9), p.e44450-e44450

2012

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans

Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma

HMGB1-Mediated Cell Death—A Crucial Element in Post-Hepatectomy Liver Failure

Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection

Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement

Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma

Perioperative and palliative systemic treatments for biliary tract cancer

Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis

Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program

Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?

Activated Mammalian Target of Rapamycin Is an Adverse Prognostic Factor in Patients with Biliary Tract Adenocarcinoma

The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer

Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer

Suchergebnisse filtern